Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
基本信息
- 批准号:10445687
- 负责人:
- 金额:$ 60.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAdoptedAdultAdvocateAffectAgeAgingAnxietyAutoimmuneAutonomic DysfunctionAutonomic nervous systemBiologicalBiological FactorsCaringCharacteristicsChildChild RearingClassificationClinicalClinical ManagementCross-Sectional StudiesDNA Sequence AlterationDataDevelopmentEnvironmental Risk FactorExecutive DysfunctionEyeFMR1FMR1 PremutationFMRPFamilyFragile X SyndromeFunctional disorderFutureGene AbnormalityGenesGeneticGenetic Predisposition to DiseaseGenotypeGleanGoalsGrowthHeart RateHigh PrevalenceImpairmentIndividualInfertilityInternationalInvestigationLifeLong-Term EffectsMental DepressionMental HealthMessenger RNAModelingMolecular AbnormalityMolecular GeneticsMothersMutateNeurodegenerative DisordersOutcomeParentsPartner in relationshipPhenotypePhysiologicalPlayPremature MenopausePreventionProcessPublic HealthRiskRisk FactorsRoleSinus ArrhythmiaStatistical MethodsStressSymptomsTestingTimeUnited StatesWomanWorkage relatedagedchronic painful conditionclinical riskdisabilitydisorder riskexecutive functionexperiencehuman old age (65+)improvedimproved outcomeinnovationlongitudinal designmenmiddle ageprematurerespiratorysocialsocial communicationsocial deficitssocial skillsstressor
项目摘要
PROJECT SUMMARY/ABSTRACT
About 1 in 151 women in the US are carriers of a genetic abnormality called the FMR1 premutation
(FXpm). Mothers who carry the FXpm are at risk for passing the mutated gene to their children, which may result
in fragile X syndrome. The FXpm is also associated with substantially increased risk for disease, including
neurodegenerative disease, premature menopause, psychiatric involvement, and executive and social deficits.
New evidence suggests that FXpm carrier mothers may experience premature age-related decline across
multiple symptom domains. The aging expression of FXpm phenotype is particularly concerning when applied
within the context of fragile X families because these symptoms impact not only the carrier mother, but also her
ability to care and advocate for her children with fragile X syndrome. However, almost all evidence of age-
related decline in this group has been gleaned from cross-sectional data that are insufficient for drawing robust
longitudinal trajectories. This represents a substantial barrier to effective clinical management, as we lack the
data needed to understand the long-term effects of the FXpm genotype and its implications for families.
This proposal seeks to determine the stability of key FXpm phenotypes (mental health, executive, social)
across midlife and early old age in FXpm carrier mothers compared to healthy controls (Aim 1); investigate
autonomic and molecular-genetic factors associated with age-related symptom expression and their interface
with parenting stress (Aim 2); and evaluate functional limitations associated with FXpm symptoms across age
(Aim 3). We will accomplish these aims by adopting an accelerated longitudinal design to track age-related
change occurring across 45-80 years in 75 FXpm carrier mothers compared to 75 control mothers. The over-
arching goal is to inform the critical age periods and risk factors in age-related decline, as well as to lay the
groundwork for future mechanistic studies. This work is necessary to develop strategies to ameliorate FXpm
symptoms, which will improve outcomes for both FXpm carrier mothers and their children with fragile X
syndrome.
项目概要/摘要
在美国,大约每 151 名女性就有 1 名携带 FMR1 前突变基因异常
(FXpm)。携带 FXpm 的母亲有将突变基因遗传给孩子的风险,这可能会导致
脆性 X 综合征。 FXpm 还与疾病风险大幅增加相关,包括
神经退行性疾病、过早绝经、精神障碍以及执行和社交缺陷。
新证据表明,FXpm 携带者母亲可能会经历与年龄相关的过早衰退
多个症状域。 FXpm 表型的衰老表达在应用时尤其令人担忧
在脆弱的 X 家庭中,因为这些症状不仅影响携带者母亲,还影响她
有能力照顾和倡导患有脆性 X 综合症的孩子。然而,几乎所有年龄的证据——
该组的相关下降是从横截面数据中收集到的,这些数据不足以绘制稳健的图
纵向轨迹。这对有效的临床管理构成了巨大障碍,因为我们缺乏
需要数据来了解 FXpm 基因型的长期影响及其对家庭的影响。
该提案旨在确定关键 FXpm 表型(心理健康、执行力、社交)的稳定性
与健康对照组相比,FXpm 携带者母亲的中年和早年情况(目标 1);调查
与年龄相关症状表达及其界面相关的自主和分子遗传因素
承受养育压力(目标 2);并评估与跨年龄 FXpm 症状相关的功能限制
(目标 3)。我们将通过采用加速纵向设计来跟踪与年龄相关的数据来实现这些目标
与 75 名对照母亲相比,75 名 FXpm 携带者母亲在 45-80 年间发生的变化。过度
首要目标是了解与年龄相关的衰退的关键年龄阶段和风险因素,并奠定基础
为未来的机理研究奠定基础。这项工作对于制定改善 FXpm 的策略是必要的
症状,这将改善 FXpm 携带者母亲及其患有脆性 X 病的孩子的结果
综合症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Klusek其他文献
Jessica Klusek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Klusek', 18)}}的其他基金
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10664902 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10712277 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10664902 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10813530 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Aging Language Trajectories in Premutation Carrier Mothers
早突变携带者母亲的衰老语言轨迹
- 批准号:
9892021 - 财政年份:2019
- 资助金额:
$ 60.67万 - 项目类别:
Defining the Language Phenotype of the FMR1 Premutation
定义 FMR1 前突变的语言表型
- 批准号:
9891045 - 财政年份:2019
- 资助金额:
$ 60.67万 - 项目类别:
Profiles and Predictors of Pragmatic Language Impairments in the FMR1 Premutation
FMR1 前突变中语用语言障碍的概况和预测因素
- 批准号:
8716154 - 财政年份:2014
- 资助金额:
$ 60.67万 - 项目类别:
Profiles and Predictors of Pragmatic Language Impairments in the FMR1 Premutation
FMR1 前突变中语用语言障碍的概况和预测因素
- 批准号:
8716154 - 财政年份:2014
- 资助金额:
$ 60.67万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
中性粒细胞胞外诱捕网(NETs)通过AIM2炎症小体促进成人斯蒂尔病髓系细胞生成并放大细胞因子风暴的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多溴联苯醚通过肠道菌群诱导维汉成人2型糖尿病的发生及抗氧化膳食模式的拮抗作用研究
- 批准号:82160605
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
DDX11突变通过激活P38MAPK/PI3K/Akt/CREB信号通路调控钙调蛋白结合蛋白促进成人AML复发的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
I型干扰素通过下调FOXO3介导NLRC4/NLRP3激活触发成人Still病炎症风暴的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10664902 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Remote STATE training for Insomnia in Older Adults
针对老年人失眠的远程 STATE 培训
- 批准号:
10393889 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Aging Symptom Trajectories in Mother Carriers of the FMR1 Premutation
FMR1 前突变母携带者的衰老症状轨迹
- 批准号:
10664902 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Remote STATE training for Insomnia in Older Adults
针对老年人失眠的远程 STATE 培训
- 批准号:
10693814 - 财政年份:2022
- 资助金额:
$ 60.67万 - 项目类别:
Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities
推进熟练护理机构中老年人的康复模式
- 批准号:
10226727 - 财政年份:2021
- 资助金额:
$ 60.67万 - 项目类别: